Rohan Kalathiya to Humans
This is a "connection" page, showing publications Rohan Kalathiya has written about Humans.
Connection Strength
0.158
-
Percutaneous Transcatheter Therapies for the Management of Left Ventricular Assist Device Complications. J Invasive Cardiol. 2017 May; 29(5):151-162.
Score: 0.020
-
Cardiac Index Declines During Long-Term Left Ventricular Device Support. Artif Organs. 2016 Dec; 40(12):1105-1112.
Score: 0.019
-
Long-term survival after pneumonectomy for non-small-cell lung cancer. Asian Cardiovasc Thorac Ann. 2013 Oct; 21(5):574-81.
Score: 0.015
-
Pneumonectomy for non-small cell lung cancer: outcomes analysis. South Med J. 2012 Jul; 105(7):350-4.
Score: 0.014
-
Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction. JACC Cardiovasc Interv. 2024 Apr 08; 17(7):920-929.
Score: 0.008
-
Use of Intravascular Ultrasound and Coronary Angiography to Measure the Prevalence of Myocardial Bridge in Heart Transplant Patients. Am J Cardiol. 2023 10 15; 205:176-181.
Score: 0.008
-
The Transulnar Approach to Coronary Angiography and Intervention: Assessing the Anatomy of the Ulnar Artery Using Angiography. J Invasive Cardiol. 2022 03; 34(3):E164-E170.
Score: 0.007
-
Concomitant Lower-Extremity Deep Vein Thrombosis in Patients With Pulmonary Embolism Undergoing Catheter-Directed Therapy. J Invasive Cardiol. 2021 Nov; 33(11):E910-E915.
Score: 0.007
-
Left Ventricular Pressure Ratio Predicts In-Hospital Outcomes in Hospitalized Heart Failure With Reduced Ejection Fraction. J Invasive Cardiol. 2021 Jul; 33(7):E507-E515.
Score: 0.007
-
Safe and rapid radial hemostasis achieved using a novel topical hemostatic patch: Results of a first-in-human pilot study using hydrophobically modified polysaccharide-chitosan. Catheter Cardiovasc Interv. 2022 02; 99(3):786-794.
Score: 0.007
-
Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease. Vascular. 2021 Jun; 29(3):355-362.
Score: 0.006
-
Single arm retrospective study of bioresorbable vascular scaffolds to treat patients with severe infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2019 Dec 01; 94(7):1028-1033.
Score: 0.006
-
Discordance Between Clinical Assessment and Invasive Hemodynamics in Patients With Advanced Heart Failure. J Card Fail. 2020 Feb; 26(2):128-135.
Score: 0.006
-
Percutaneous Transapical Left Ventricular Access to Treat Paravalvular Leak and Ventricular Septal Defect. J Invasive Cardiol. 2019 Sep; 31(9):247-252.
Score: 0.006
-
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial. JACC Heart Fail. 2018 10; 6(10):859-870.
Score: 0.005
-
Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis. J Heart Lung Transplant. 2016 07; 35(7):868-76.
Score: 0.005
-
One-and-done: Do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension? J Heart Lung Transplant. 2015 Dec; 34(12):1637-9.
Score: 0.004
-
Volume Overload in Heart Failure: An Evidence-Based Review of Strategies for Treatment and Prevention. Mayo Clin Proc. 2015 Sep; 90(9):1247-61.
Score: 0.004
-
Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk. Am J Cardiol. 2015 Jan 01; 115(1):34-9.
Score: 0.004